# Effects of Different Early Intensive Therapies on Long-term β-cell Function

> **NCT01471808** · PHASE4 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 264 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** CSII
- **DRUG:** CSII, Metformin, Pioglitazone
- **DRUG:** CSII, Sitagliptin

## Key facts

- **NCT ID:** NCT01471808
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01471808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01471808, "Effects of Different Early Intensive Therapies on Long-term β-cell Function". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01471808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*